Clinicians should learn how to identify pellucid and screen patients for it prior to refractive surgery, according to Yaron Rabinowitz, MD, director of ophthalmology research, Cedars Sinai Medical Center, Los Angeles, USA.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
2 Commerce Drive
Cranbury, NJ 08512